(1)
Lebwohl, M.; Green, L.; Bettencourt, M.; Fretzin, S.; Jacobson, A. Long-Term Efficacy and Safety of Brodalumab in Patients With Psoriasis Whose Disease Did Not Respond to Prior Biologics. J of Skin 2019, 3, S22.